New Egyptian Journal of Medicine [The]. 2008; 38 (5): 309-316
in English
| IMEMR
| ID: emr-101538
ABSTRACT
B-type natruretic peptide [B.N.P] is cardiac neurohornone specifically secreted from the ventricles in response to volume expansion and pressure overload. Levels of [B.N.P] are elevated in patients with left ventricular dysfunction. B.N.P testing is best used as a rule out test, for suspected cases of new heart failure in breathless patients. as a matter of fact it is not a replacement for echocardiography and full cardiological assessment. which will be required for patients with an elevated BNP concentration. B.N.P levels rise with age and are affected by gender, drug therapy such as diuretics, beta-blockers and renal failure, it can not stand alone as a diagnostic test, physical examination and chest X-ray and ECG should be globically studied. The importance of this study in heart failure practice are diagnosis, screenings of asymptomatic left ventricular dysfunction, risk stratification, prognostification, and treatment monitoring
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Prognosis
/
Atrial Natriuretic Factor
/
Ventricular Dysfunction, Left
/
Heart Failure
/
Myocardial Infarction
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
New Egypt. J. Med.
Year:
2008
Similar
MEDLINE
...
LILACS
LIS